GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GRI Bio, Inc. (GRI) | 8/14/2026 7:53:32 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $11,380,000 | EPS -$0.91 | ||
| GRI Bio, Inc. (GRI) | 5/13/2026 4:21:51 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $11,339,000 | EPS -$1.61 | ||
| GRI Bio, Inc. (GRI) | 2/4/2026 8:49:54 AM | View | Financials | Earnings | SEC | Y 2025 | Assets $8,666,000 | EPS -$116.61 | Export Earnings Model | ||
| GRI Bio, Inc. (GRI) | 1/30/2026 7:44:20 AM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $8,666,000 | EPS -$121.80 | ||
| GRI Bio, Inc. (GRI) | 12/29/2025 8:09:25 AM | View | Proxy | SEC | Y 2024 | ||||||
| GRI Bio, Inc. (GRI) | 11/14/2025 7:53:20 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $4,782,000 | EPS -$1.28 | ||
| GRI Bio, Inc. (GRI) | 8/14/2025 7:02:56 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $5,675,000 | EPS -$1.31 | ||
| GRI Bio, Inc. (GRI) | 7/11/2025 4:19:56 PM | View | Proxy | SEC | Y 2024 | ||||||
| GRI Bio, Inc. (GRI) | 5/15/2025 8:46:15 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $4,042,000 | EPS -$5.80 | ||
| GRI Bio, Inc. (GRI) | 5/15/2025 8:36:28 AM | View | Financials | Earnings | SEC | 1Q 2025 | Assets $4,042,000 | EPS -$5.80 | Export Earnings Model | ||
| GRI Bio, Inc. (GRI) | 3/17/2025 8:07:23 AM | View | Financials | Earnings | SEC | Y 2024 | Assets $5,739,000 | EPS -$50.65 | Export Earnings Model | ||
| GRI Bio, Inc. (GRI) | 3/14/2025 5:14:54 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $5,739,000 | EPS -$55.21 | ||
| GRI Bio, Inc. (GRI) | 1/17/2025 4:05:55 PM | View | Proxy | SEC | Y 2024 | ||||||
| GRI Bio, Inc. (GRI) | 11/14/2024 4:30:45 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $5,459,000 | EPS -$0.67 | ||
| GRI Bio, Inc. (GRI) | 11/14/2024 4:27:30 PM | View | Financials | Earnings | SEC | 3Q 2024 | Assets $5,459,000 | EPS -$0.67 | Export Earnings Model | ||
| GRI BIO, Inc. (GRI) | 8/14/2024 8:08:38 AM | View | Financials | Earnings | SEC | 2Q 2024 | Assets $7,031,000 | EPS -$4.92 | Export Earnings Model | ||
| GRI BIO, Inc. (GRI) | 8/14/2024 6:17:30 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $7,031,000 | EPS -$4.92 | ||
| GRI BIO, Inc. (GRI) | 8/2/2024 5:21:06 PM | View | Proxy | SEC | Y 2023 | ||||||
| GRI BIO, Inc. (GRI) | 5/13/2024 8:04:16 AM | View | Financials | Earnings | SEC | 1Q 2024 | Assets $4,587,000 | EPS -$0.46 | Export Earnings Model | ||
| GRI BIO, Inc. (GRI) | 5/10/2024 5:07:16 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $4,587,000 | EPS -$0.46 | ||
| GRI BIO, Inc. (GRI) | 5/9/2024 4:32:20 PM | View | Proxy | SEC | Y 2023 | ||||||
| GRI BIO, Inc. (GRI) | 4/1/2024 9:14:49 AM | View | Financials | Earnings | SEC | Y 2023 | Assets $2,956,000 | EPS -$24.42 | Export Earnings Model | ||
| GRI BIO, Inc. (GRI) | 3/28/2024 4:38:35 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $2,956,000 | EPS -$28.25 | ||
| GRI BIO, Inc. (GRI) | 1/2/2024 6:02:08 AM | View | Proxy | SEC | Y 2023 | ||||||
| GRI BIO, Inc. (GRI) | 11/15/2023 8:11:53 AM | View | Financials | Earnings | SEC | 3Q 2023 | Assets $4,404,000 | EPS -$0.52 | Export Earnings Model | ||
| GRI BIO, Inc. (GRI) | 11/14/2023 8:47:37 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $4,404,000 | EPS -$0.52 | ||
| GRI BIO, Inc. (GRI) | 8/14/2023 8:15:56 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $5,642,000 | EPS -$2.79 | ||
| GRI BIO, Inc. (GRI) | 8/14/2023 8:08:27 AM | View | Financials | Earnings | SEC | 2Q 2023 | Assets $5,642,000 | EPS -$2.79 | Export Earnings Model | ||
| GRI BIO, Inc. (GRI) | 5/26/2023 4:19:58 PM | View | Proxy | SEC | Y 2022 | ||||||
| GRI BIO, Inc. (GRI) | 5/15/2023 5:10:58 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Rev: $16,000 | Assets $2,097,000 | EPS -$5.33 | |
| Vallon Pharmaceuticals, Inc. (GRI) | 2/24/2023 7:35:33 AM | View | Financials | Earnings | SEC | Y 2022 | Assets $4,152,000 | EPS -$0.10 | Export Earnings Model | ||
| Vallon Pharmaceuticals, Inc. (GRI) | 2/24/2023 6:17:54 AM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $4,152,000 | EPS -$0.69 | ||
| Vallon Pharmaceuticals, Inc. (GRI) | 11/3/2022 4:47:08 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $5,569,000 | EPS -$0.09 | ||
| Vallon Pharmaceuticals, Inc. (GRI) | 11/3/2022 4:44:10 PM | View | Financials | Earnings | SEC | 3Q 2022 | Assets $5,569,000 | EPS -$0.09 | Export Earnings Model | ||
| Vallon Pharmaceuticals, Inc. (GRI) | 7/28/2022 8:17:58 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $8,007,000 | EPS -$0.20 | ||
| Vallon Pharmaceuticals, Inc. (GRI) | 7/28/2022 8:06:30 AM | View | Financials | Earnings | SEC | 2Q 2022 | Rev ($1,000) | Assets $8,007,000 | EPS -$0.20 | Export Earnings Model | |
| Vallon Pharmaceuticals, Inc. (GRI) | 6/6/2022 5:13:37 PM | View | Proxy | SEC | Y 2021 | ||||||
| Vallon Pharmaceuticals, Inc. (GRI) | 5/9/2022 4:38:00 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $5,944,000 | EPS -$0.39 | ||
| Vallon Pharmaceuticals, Inc. (GRI) | 5/9/2022 4:12:32 PM | View | Financials | Earnings | SEC | 1Q 2022 | Rev $0 | Assets $5,944,000 | EPS -$0.39 | Export Earnings Model | |
| Vallon Pharmaceuticals, Inc. (GRI) | 4/27/2022 4:12:27 PM | View | Proxy | SEC | Y 2021 | ||||||
| Vallon Pharmaceuticals, Inc. (GRI) | 3/21/2022 7:12:51 AM | View | Financials | Earnings | WIRE | Y 2021 | Assets $8,335,000 | EPS -$0.46 | Export Earnings Model | ||
| Vallon Pharmaceuticals, Inc. (GRI) | 2/14/2022 4:40:58 PM | View | Financials | Earnings | SEC | Y 2021 | Assets $8,335,000 | EPS -$0.46 | Export Earnings Model | ||
| Vallon Pharmaceuticals, Inc. (GRI) | 2/14/2022 4:34:38 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $8,335,000 | EPS -$1.42 | ||
| Vallon Pharmaceuticals, Inc. (GRI) | 11/12/2021 8:15:54 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $10,140,000 | EPS -$0.18 | ||
| Vallon Pharmaceuticals, Inc. (GRI) | 11/12/2021 8:10:29 AM | View | Financials | Earnings | SEC | 3Q 2021 | Rev $0 | Assets $10,140,000 | EPS -$0.18 | Export Earnings Model | |
| Vallon Pharmaceuticals, Inc. (GRI) | 8/10/2021 8:23:46 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | Assets $11,647,000 | EPS -$0.34 | ||
| Vallon Pharmaceuticals, Inc. (GRI) | 8/10/2021 8:07:03 AM | View | Financials | Earnings | SEC | 2Q 2021 | Rev ($2,000) | Assets $11,647,000 | EPS -$0.34 | Export Earnings Model | |
| Vallon Pharmaceuticals, Inc. (GRI) | 5/13/2021 9:21:53 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | Assets $14,600,000 | EPS -$0.46 | ||
| Vallon Pharmaceuticals, Inc. (GRI) | 5/13/2021 8:47:10 AM | View | Earnings | SEC | 1Q 2021 | Rev $0 | Assets $14,600,000 | EPS -$0.46 |